These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 22926853

  • 1. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
    Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, Käsmann-Kellner B, Papanagiotou P, Schäffler N, Restemeyer C, Bittersohl D, Hassenstein A, Seitz B, Reith W, Fassbender K, Hilgers R, Heesen C, Bähr M, Diem R.
    Ann Neurol; 2012 Aug; 72(2):199-210. PubMed ID: 22926853
    [Abstract] [Full Text] [Related]

  • 2. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP, Altmann DR, Trip AS, Kallis C, Jones SJ, Schlottmann PG, Garway-Heath DF, Plant GT, Miller DH.
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
    Roed HG, Langkilde A, Sellebjerg F, Lauritzen M, Bang P, Mørup A, Frederiksen JL.
    Neurology; 2005 Mar 08; 64(5):804-10. PubMed ID: 15753413
    [Abstract] [Full Text] [Related]

  • 4. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
    Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, Pablo L, Honrubia F.
    Mult Scler; 2008 Jun 08; 14(5):609-14. PubMed ID: 18424482
    [Abstract] [Full Text] [Related]

  • 5. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
    Diem R, Molnar F, Beisse F, Gross N, Drüschler K, Heinrich SP, Joachimsen L, Rauer S, Pielen A, Sühs KW, Linker RA, Huchzermeyer C, Albrecht P, Hassenstein A, Aktas O, Guthoff T, Tonagel F, Kernstock C, Hartmann K, Kümpfel T, Hein K, van Oterendorp C, Grotejohann B, Ihorst G, Maurer J, Müller M, Volkmann M, Wildemann B, Platten M, Wick W, Heesen C, Schiefer U, Wolf S, Lagrèze WA.
    BMJ Open; 2016 Mar 01; 6(3):e010956. PubMed ID: 26932144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
    Shayegannejad V, Shahzamani S, Dehghani A, Dast Borhan Z, Rahimi M, Mirmohammadsadeghi A.
    Graefes Arch Clin Exp Ophthalmol; 2015 May 01; 253(5):797-801. PubMed ID: 25605544
    [Abstract] [Full Text] [Related]

  • 8. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis.
    Pro MJ, Pons ME, Liebmann JM, Ritch R, Zafar S, Lefton D, Kupersmith MJ.
    J Neurol Sci; 2006 Dec 01; 250(1-2):114-9. PubMed ID: 17027854
    [Abstract] [Full Text] [Related]

  • 9. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L, Castelnovo G, Carlander B, Villain M, Mura F, Dupeyron G, Labauge P.
    Rev Neurol (Paris); 2008 Nov 01; 164(11):927-34. PubMed ID: 18808761
    [Abstract] [Full Text] [Related]

  • 10. Early factors associated with axonal loss after optic neuritis.
    Henderson AP, Altmann DR, Trip SA, Miszkiel KA, Schlottmann PG, Jones SJ, Garway-Heath DF, Plant GT, Miller DH.
    Ann Neurol; 2011 Dec 01; 70(6):955-63. PubMed ID: 22190367
    [Abstract] [Full Text] [Related]

  • 11. Axonal loss and myelin in early ON loss in postacute optic neuritis.
    Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, O'Day J, Grigg J, Billson F, Yiannikas C.
    Ann Neurol; 2008 Sep 01; 64(3):325-31. PubMed ID: 18825673
    [Abstract] [Full Text] [Related]

  • 12. Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
    Sühs KW, Papanagiotou P, Hein K, Pul R, Scholz K, Heesen C, Diem R.
    Int J Mol Sci; 2016 Sep 30; 17(10):. PubMed ID: 27706045
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study.
    Lagrèze WA, Küchlin S, Ihorst G, Grotejohann B, Beisse F, Volkmann M, Heinrich SP, Albrecht P, Ungewiss J, Wörner M, Hug MJ, Wolf S, Diem R, TONE study group.
    Lancet Neurol; 2021 Dec 30; 20(12):991-1000. PubMed ID: 34800417
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic validity of optic disc and retinal nerve fiber layer evaluations in detecting structural changes after optic neuritis.
    Bertuzzi F, Suzani M, Tagliabue E, Cavaletti G, Angeli R, Balgera R, Rulli E, Ferrarese C, Miglior S.
    Ophthalmology; 2010 Jun 30; 117(6):1256-1264.e1. PubMed ID: 20381872
    [Abstract] [Full Text] [Related]

  • 15. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR.
    N Engl J Med; 1992 Feb 27; 326(9):581-8. PubMed ID: 1734247
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.
    Chatziralli IP, Moschos MM, Brouzas D, Kopsidas K, Ladas ID.
    Clin Exp Optom; 2012 Mar 27; 95(2):223-8. PubMed ID: 22329676
    [Abstract] [Full Text] [Related]

  • 17. Randomized control trial of evaluation of Clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis.
    Moghaddasi M, Nabovvati M, Koushki A, Soltansanjari M, Sardarinia M, Mohebi N, Rabani S.
    Clin Neurol Neurosurg; 2020 Jun 27; 193():105741. PubMed ID: 32145678
    [Abstract] [Full Text] [Related]

  • 18. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ.
    Ophthalmology; 2006 Feb 27; 113(2):324-32. PubMed ID: 16406539
    [Abstract] [Full Text] [Related]

  • 19. Optic neuritis with visual field defect--possible Ibuprofen-related toxicity.
    Gamulescu MA, Schalke B, Schuierer G, Gabel VP.
    Ann Pharmacother; 2006 Mar 27; 40(3):571-3. PubMed ID: 16507621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.